Unibest
← Back to patent-cliff list

Alosetron Hydrochloride

Tier C — Watch / trade

Alosetron Hydrochloride

Prometheus Inc
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:5-HT3

Brand:Lotronex

Indications (approved):Irritable bowel syndrome

Regional status

US
Approved
2000-02-09
EU
-
China
Discontinued
2009-08-31
Japan
-

Synthetic routes & intermediates3 routes

Originator routes × 1Optimised (non-patent) × 2Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 3 · Total yield 352 mg
ALOS-00150776-26-6ALOS-002122852-74-8ALOS-003122852-75-9ALOS-004131099-78-0API · Alosetron Hydrochloride
CodeCAS No.Intermediate
ALOS-00150776-26-64-methyl-3,4-dihydrocyclopenta[b]indol-1(2H)-one
ALOS-002122852-74-8(E)-4-methyl-3,4-dihydrocyclopenta[b]indol-1(2H)-one oxime
ALOS-003122852-75-95-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one
ALOS-004131099-78-05-(chloromethyl)-4-methyl-1-trityl-1H-imidazole
OptimisedRoute 2Steps 2 · Total yield 7.8 g
ALOS-003122852-75-9ALOS-00529636-87-1ALOS-006307504-13-8API · Alosetron Hydrochloride
CodeCAS No.Intermediate
ALOS-003122852-75-95-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one
ALOS-00529636-87-1(4-methyl-1H-imidazol-5-yl)methanol
ALOS-006307504-13-8tert-butyl 5-(hydroxymethyl)-4-methyl-1H-imidazole-1-carboxylate
OptimisedRoute 3Steps 3 · Total yield /
ALOS-0077088-88-2ALOS-008122853-01-4ALOS-009—ALOS-010122853-02-5API · Alosetron Hydrochloride
CodeCAS No.Intermediate
ALOS-0077088-88-22-(1-methyl-1H-indol-2-yl)ethan-1-amine
ALOS-008122853-01-42,2,2-trifluoro-N-(2-(1-methyl-1H-indol-2-yl)ethyl)acetamide
ALOS-009-5-(chloromethyl)-N,N,4-trimethyl-1H-imidazole-1-sulfonamide
ALOS-010122853-02-5N-((1-(N,N-dimethylsulfamoyl)-5-methyl-1H-imidazol-4-yl)methyl)-2,2,2-trifluoro-N-(2-(1-methyl-1H-indol-2-yl)ethyl)acetamide

Frequently asked questions

What are the approved indications of Alosetron Hydrochloride?

Approved indications include: Irritable bowel syndrome.

When does the Alosetron Hydrochloride patent expire?

No public expiry year is available for Alosetron Hydrochloride yet; this page updates once verified.

How many synthesis routes are recorded for Alosetron Hydrochloride?

3 synthesis routes are recorded; the shortest is 2 steps with 7.8 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Alosetron Hydrochloride intermediates?

All intermediates in Alosetron Hydrochloride routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Alosetron Hydrochloride intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29